TSWM
AUPH icon

Tyler-Stone Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Tyler-Stone Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$9K – 831
2021
Q4 		$9K Buy
+400
New +$9.48K ﹤0.01% 623

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Tyler-Stone Wealth Management's AUPH Position: Q1 2022 in Review

Tyler-Stone Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2022, closing a stake of 400 shares — an estimated $9K sold.

Tyler-Stone Wealth Management first reported a position in AUPH in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 184 funds tracked by Wall St. Rank hold AUPH as of Q1 2022.

  • Tyler-Stone Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 400 Aurinia Pharmaceuticals shares in Q1 2022, an estimated $9K.
  • Tyler-Stone Wealth Management first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Tyler-Stone Wealth Management's Aurinia Pharmaceuticals position peaked at $9K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.